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nhibition of macrophage migration inhibitory factor reduces
engue virus replication in human hepatoma cells
.-M. Yeh1,∗, Y.-C. Chuang2
National Cheng Kung University, Tainan, Taiwan, R.O.C
National Cheng Kung University, Tainan city, Taiwan, R.O.C
Background: Dengue virus (DENV) infection can cause life-
hreatening dengue hemorrhage fever and shock syndrome
DHF/DSS). Currently there is no effective treatment to prevent
he development of DHF/DSS, except supporting care. Macrophage
igration inhibitory factor (MIF) is a pro-inﬂammatory cytokine
hat plays important roles in the pathogenesis of DHF/DSS. Because
utophagy is involved in DENV replication and MIF can induce cell
utophagy through thegenerationof reactiveoxygenspecies (ROS),
he effect of MIF on DENV replication was studied.
Methods: DENV infection of human hepatoma cell line Huh-
cells, with or without the presence of MIF inhibitor, ISO-1 or
OS scavenger N-acetyl-L-cysteine (NAC), was detected by anti-
S1 antibody and ﬂow cytometry. In addiiton, MIF knockdown
ells were generated by shRNA to compare virus replication and
utophagy formation (LC3-II expression) induced by DENV infec-
ion.
Results: In the presence of ISO-1 as well as NAC, DENV repli-
ation in Huh-7 cells was reduced. Diminished MIF expression
y shRNA transfection further conﬁrmed DENV replication and
utophagy induced byDENVwere reduced inMIF knockdown cells.
Conclusion: Taken together, these data suggest that blocking
IF by its inhibitor or antibody may not only reduce proinﬂamma-
ory response but also virus replication during DENV infection.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.274
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he association between dengue virus (DENV) genotype (G) and
engue disease severity
.F. Yung1,∗, J.G. Wong1, D.K.S. Lee2, V. Gan1, T.L. Thein1, D.C.
ye1, L.C. Ng2, Y.S. Leo1
Tan Tock Seng Hospital, Singapore, Singapore
National Environment Agency, Singapore, Singapore
Background: The role of genotypic variation between and
ithin dengue virus serotypes in disease severity, outbreak poten-
ial and vectorial capacity has been suggested in previous studies.
e explored the association between dengue genotypes and dis-ase severity using World Health Organization (WHO) criteria for
engue hemorrhagic fever (DHF), severe dengue (SD) and warning
igns (WS).nfectious Diseases 16S (2012) e2–e157
Methods: Sequencing of DENV E-gene from 110 viremic sub-
jects was performed. Phylogenetic analysis was carried out using
ClustalX and compared with global dengue isolates in Genbank.
Disease severity was classiﬁed using clinical and laboratory data
into DHF (WHO 1997) and WS (WHO 2009). SD was not studied
further because of small numbers.
Results:Our prospective adult dengue cohort comprisedDENV-
1 G1 (12 cases), DENV-1 G3 (3 cases), DENV-2 Cosmopolitan Clade I
(7 cases),DENV-2CosmopolitanClade II, III and IV (72cases),DENV-
2 Indian clade (5 cases), DENV-3 G1 (5 cases), DENV3 G2 (1 case),
DENV-3 G3 (1 case), and DENV-4 G2 (4 cases). There were 44 DHF
cases and 68 cases with at least one WS. We found no signiﬁcant
association among dengue genotype DENV-1 G1 [p=0.53], DENV-
2 Cosmopolitan Clade I [p=0.24], DENV-2 Cosmopolitan Clade II,
III and IV [p=0.93], DENV-2 Indian clade [p=0.65] and DENV-3 G1
[p=0.39] and DHF. Analysis of disease severity among different
cladesofDENV-2after controlling forhospitalizationstatus showed
infection by DENV-2 Cosmopolitan Clade II, III and IV signiﬁcantly
increased the risk of DHF versus DENV-2 Cosmopolitan Clade I and
DENV-2 Indian clade (adjusted OR 10.1, 95% conﬁdence interval
1.6-63). There was no statistically signiﬁcant association between
presence of any WS and DENV-2 Cosmopolitan Clade II, III and IV.
Conclusion: Dengue infection from DENV-1 G1, DENV-2 Cos-
mopolitanClade I,DENV-2CosmopolitanClade II, III and IV,DENV-2
Indian clade or DENV-3 G1 were not associated with greater risk of
DHF. However, within DENV-2 serotype, individuals infected with
DENV-2 Cosmopolitan Clade II, III and IV may be more likely to
develop DHF versus infections with DENV-2 Cosmopolitan Clade
I or DENV-2 Indian clade. The former group of viruses have been
associated with outbreaks in Singapore in 2007 and 2011.
http://dx.doi.org/10.1016/j.ijid.2012.05.275
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Detectionofherpes simplexvirus infection inmucosal andcuta-
neous ulcers of the suspected patients by real-time PCR
M. Ziyaeyan ∗, M. Namayandeh
Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of
Background: Diagnosis of herpetic skin infection and distin-
guishing between herpes simplex virus (HSV) infection and other
infections are sometimes difﬁcult. Rapid and accurate detection of
HSV is crucial to clinical diagnosis and therapy.The aimof this study
was todetect theHSVDNA in skin samplesof the suspectedpatients
by real-time PCR.
Methods: The study population consisted of89 male and 78
female patients (n=167). Specimens were collected from various
anatomical sites including 53face or lips,48 oral cavity,27 genital,
16ﬁngers, and 23 other body parts. Cotton swabs were sent to the
laboratory in buffered saline or viral transport medium. DNA was
extracted using an invisorb spin virus DNA Isolation Kit according
to the manufacturer’s instructions. Real-Time PCR was performed
on the puriﬁed DNA using a standard HSV PCR kit.Results: The majority (60.4%) of the samples were from face,
lips and oral cavity. All the genital lesions samples were taken by
gynecologists. HSVDNAwas detected in 17 of 53 patientswith face
or lip ulcers (32%), 19 of 48 patientswith oralmucosa lesions (39%),
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2 of 27 patients with genital involvement (81%), 11 of 16 patients
ith whitlow ulcers (69%), and in 5 of 23 patients with other body
arts ulcers (22%).
Conclusion: Taking into account the high sensitivity, repro-
ucibility and speciﬁcity, the real-time PCR assay can be used for
he rapid detection of HSV DNA from skin origin clinical samples,
specially in difﬁcult clinical cases.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.276
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ctivity of Tigecycline and comparators against aerobic intra-
bdominal pathogens in Asia/Paciﬁc: 2004 - 2011
. Badal1,∗, M. Hackel1, S. Bouchillon1, B. Johnson1, D. Hoban1, S.
awser2, M. Dowzicky3nfectious Diseases 16S (2012) e2–e157 e121
1 International Health Management Associates, Inc., Schaumburg, IL,
USA
2 IHMA Europe Sàrl, Epalinges, Switzerland
3 Pﬁzer Inc., Collegeville, PA, USA
Background: Bacterial resistance due to beta-lactamases and
other mechanisms has continued to increase over the past sev-
eral years, particularly in Asia/Paciﬁc; however, tigecycline has
thus far retained a broad spectrum of activity against many of the
species which have become largely resistant to other antimicro-
bics. The Tigecycline Evaluation Surveillance Trial (TEST) program
is an ongoing global surveillance study which has tracked in vitro
activity of several drugs since 2004. This report from TEST sum-
marizes the susceptibility of aerobic pathogens of intra-abdominal
infections (IAI) in Asia/Paciﬁc from 2004-2011.
Methods: 975 aerobic isolates from IAI sources were collected
from 12 Asia/Paciﬁc countries from 2004-2011. Isolates were iden-
tiﬁed to the species level at participating sites and conﬁrmed by a
central laboratory in the USA. Minimum Inhibitory Concentrations
(MICs) were determined at each site using supplied broth microdi-
lution panels and interpreted according to CLSI/FDA guidelines.
Results: Susceptibility percentages for species with n≥10 are
summarized below; values ≥90% are shaded:
igecycline’s MIC90 vs. A. baumannii and Acinetobacter spp. were
2 and 1 mcg/ml, respectively.
Conclusion: Tigecycline inhibited >90% of all tested species for
which breakpoints exist. Like all tetracycline derivatives, tigecy-
cline has poor activity vs. P. aeruginosa. Although there are no
breakpoints established for tigecycline and Acinetobacter spp., its
in vitro activity against these often multi-drug-resistant (MDR)
organisms is interesting given the diminishing treatment options
for infections caused by MDR A. baumannii. Tigecycline retains
excellent in vitro activity against most of the species causing these
infections.
http://dx.doi.org/10.1016/j.ijid.2012.05.277
